PIK3CD and diffuse large B-cell lymphoma: Similar effects of CAL-101 and other p110δ inhibitors have been observed on other B-cell malignancies such as MM, DLBCL, and HL (Ikeda et al., 2010; Lannutti et al., 2011; Meadows et al., 2012) (Table 2).